Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1986 Jun;52(3):846–852. doi: 10.1128/iai.52.3.846-852.1986

Pulmonary microvascular injury induced by Pseudomonas aeruginosa cytotoxin in isolated rabbit lungs.

W Seeger, D Walmrath, H Neuhof, F Lutz
PMCID: PMC260937  PMID: 3519462

Abstract

The effects of Pseudomonas aeruginosa cytotoxin on the pulmonary microvasculature were studied in blood-free, perfused, isolated rabbit lungs. Cytotoxin was administered to the recirculating Krebs Henseleit albumin (1%) buffer during two consecutive 30-min-perfusion phases (phases 1 and 2) at a concentration of 13 micrograms/ml, followed by a third perfusion phase (phase 3) without toxin. After perfusion phases 2 and 3, the capillary filtration coefficient (Kf,c) and vascular compliance were determined gravimetrically from two-step microvascular pressure increments under zero-flow conditions. Cytotoxin caused a continuous release of K+ and lactate dehydrogenase, which started within the first 5 min and amounted to about 50% of the total lung cellular K+ and 5 to 7% of the total lactate dehydrogenase by the end of the experiment. The toxin caused the continuous generation of prostaglandin I2, which was detectable in the perfusates of all perfusion phases at maximum values five times above the control values and which was measured in the bronchoalveolar lavage fluid at the end of the experiment. Thromboxane generation in toxin-treated lungs did not significantly exceed that of control lungs or of lungs with mechanically induced edema. Cytotoxin caused a gradual increase in pulmonary vascular resistance, to maximum values 2.5 times above the control, starting within 1 min; the increase was partially reversible after washout of the toxin. After a lag period of 20 to 30 min, the lungs gained weight, amounting to a mean gain of 9.1 g at the end of the experiments. After perfusion phases 2 and 3, an almost fourfold increase in Kf,c, which was not reversible after washout of the toxin, was measured, whereas the values of vascular compliance were not altered. We conclude that pseudomonal cytotoxin may be an important factor in the pathogenesis of prolonged microvascular injury, encountered in states of P. aeruginosa sepsis or acute lung failure with secondarily acquired P. aeruginosa pneumonia.

Full text

PDF
847

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andriole V. T. Pseudomonas bacteremia: can antibiotic therapy improve survival? J Lab Clin Med. 1979 Aug;94(2):196–200. [PubMed] [Google Scholar]
  2. Baltch A. L., Griffin P. E. Pseudomonas aeruginosa bacteremia: a clinical study of 75 patients. Am J Med Sci. 1977 Sep-Oct;274(2):119–129. [PubMed] [Google Scholar]
  3. Baltch A. L., Hammer M. C., Smith R. P., Obrig T. G., Conroy J. V., Bishop M. B., Egy M. A., Lutz F. Effects of Pseudomonas aeruginosa cytotoxin on human serum and granulocytes and their microbicidal, phagocytic, and chemotactic functions. Infect Immun. 1985 May;48(2):498–506. doi: 10.1128/iai.48.2.498-506.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brigham K. L., Meyrick B. Interactions of granulocytes with the lungs. Circ Res. 1984 Jun;54(6):623–635. doi: 10.1161/01.res.54.6.623. [DOI] [PubMed] [Google Scholar]
  5. Brigham K. L., Woolverton W. C., Blake L. H., Staub N. C. Increased sheep lung vascular permeability caused by pseudomonas bacteremia. J Clin Invest. 1974 Oct;54(4):792–804. doi: 10.1172/JCI107819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cintora I., Bessa S., Goodale R. L., Jr, Motsay G. W., Borner J. W. Further studies of endotoxin and alveolocapillary permeability: effect of steroid pre-treatment and complement depletion. Ann Surg. 1974 Mar;179(3):372–375. doi: 10.1097/00000658-197403000-00020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Clowes G. H., Jr, Hirsch E., Williams L., Kwasnik E., O'Donnell T. F., Cuevas P., Saini V. K., Moradi I., Farizan M., Saravis C. Septic lung and shock lung in man. Ann Surg. 1975 May;181(5):681–692. doi: 10.1097/00000658-197505000-00024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Crocker S. H., Eddy D. O., Obenauf R. N., Wismar B. L., Lowery B. D. Bacteremia: host-specific lung clearance and pulmonary failure. J Trauma. 1981 Mar;21(3):215–220. [PubMed] [Google Scholar]
  9. Cryz S. J. New insights into the epidemiology, pathogenesis and therapy of Pseudomonas aeruginosa infections. Eur J Clin Microbiol. 1985 Apr;4(2):153–155. doi: 10.1007/BF02013588. [DOI] [PubMed] [Google Scholar]
  10. Drake R. E., Gabel J. C. Comparison of techniques to measure pulmonary capillary filtration coefficients in dogs. Microvasc Res. 1981 Mar;21(2):133–141. doi: 10.1016/0026-2862(81)90026-1. [DOI] [PubMed] [Google Scholar]
  11. Dunn M. M., Toews G. B., Hart D., Pierce A. K. The effects of systemic immunization of pulmonary clearance of Pseudomonas aeruginosa. Am Rev Respir Dis. 1985 Mar;131(3):426–431. doi: 10.1164/arrd.1985.131.3.426. [DOI] [PubMed] [Google Scholar]
  12. Flick M. R., Cluff L. E. Pseudomonas bacteremia. Review of 108 cases. Am J Med. 1976 Apr;60(4):501–508. doi: 10.1016/0002-9343(76)90716-6. [DOI] [PubMed] [Google Scholar]
  13. Frimmer M., Homann J., Petzinger E., Rufeger U., Scharmann W. Comparative studies on isolated rat hepatocytes and AS-30D hepatoma cells with leucocidin from Pseudomonas aeruginosa. Naunyn Schmiedebergs Arch Pharmacol. 1976 Oct;295(1):63–69. doi: 10.1007/BF00509774. [DOI] [PubMed] [Google Scholar]
  14. Füssle R., Bhakdi S., Sziegoleit A., Tranum-Jensen J., Kranz T., Wellensiek H. J. On the mechanism of membrane damage by Staphylococcus aureus alpha-toxin. J Cell Biol. 1981 Oct;91(1):83–94. doi: 10.1083/jcb.91.1.83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Glauser F. L., Fairman R. P. The uncertain role of the neutrophil in increased permeability pulmonary edema. Chest. 1985 Oct;88(4):601–607. doi: 10.1378/chest.88.4.601. [DOI] [PubMed] [Google Scholar]
  16. Gorin A. B., Hasagawa G., Hollinger M., Sperry J., Zuckerman J. Release of angiotensin converting enzyme by the lung after Pseudomonas bacteremia in sheep. J Clin Invest. 1981 Jul;68(1):163–170. doi: 10.1172/JCI110232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Graybill J. R., Marshall L. W., Charache P., Wallace C. K., Melvin V. B. Nosocomial pneumonia. A continuing major problem. Am Rev Respir Dis. 1973 Nov;108(5):1130–1140. doi: 10.1164/arrd.1973.108.5.1130. [DOI] [PubMed] [Google Scholar]
  18. Hofman W. F., Ehrhart I. C. Permeability edema in dog lung depleted of blood components. J Appl Physiol Respir Environ Exerc Physiol. 1984 Jul;57(1):147–153. doi: 10.1152/jappl.1984.57.1.147. [DOI] [PubMed] [Google Scholar]
  19. Kaplan R. L., Sahn S. A., Petty T. L. Incidence and outcome of the respiratory distress syndrome in gram-negative sepsis. Arch Intern Med. 1979 Aug;139(8):867–869. [PubMed] [Google Scholar]
  20. LaForce F. M. Hospital-acquired gram-negative rod pneumonias: an overview. Am J Med. 1981 Mar;70(3):664–669. doi: 10.1016/0002-9343(81)90593-3. [DOI] [PubMed] [Google Scholar]
  21. Lind T., McDonald J. A., Avioli L. V. Grand Rounds: Adult respiratory distress syndrome. Arch Intern Med. 1981 Dec;141(13):1749–1753. doi: 10.1001/archinte.141.13.1749. [DOI] [PubMed] [Google Scholar]
  22. Lunde P. K., Waaler B. A. Transvascular fluid balance in the lung. J Physiol. 1969 Nov;205(1):1–18. doi: 10.1113/jphysiol.1969.sp008947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Lutz F., Grieshaber S., Schmidt K. Permeability changes of Ehrlich mouse ascites tumor cells induced by a cytotoxin from Pseudomonas aeruginosa. Naunyn Schmiedebergs Arch Pharmacol. 1982 Jul;320(1):78–80. doi: 10.1007/BF00499077. [DOI] [PubMed] [Google Scholar]
  24. Lutz F. Interaction of Pseudomonas aeruginosa cytotoxin with plasma membranes from Ehrlich ascites tumor cells. Naunyn Schmiedebergs Arch Pharmacol. 1986 Jan;332(1):103–110. doi: 10.1007/BF00633206. [DOI] [PubMed] [Google Scholar]
  25. Lutz F. Purification of a cytotoxic protein from Pseudomonas aeruginosa. Toxicon. 1979;17(5):467–475. doi: 10.1016/0041-0101(79)90280-0. [DOI] [PubMed] [Google Scholar]
  26. Magno M., Atkinson B., Katz A., Fishman A. P. Estimation of pulmonary interstitial fluid space compliance in isolated perfused rabbit lung. J Appl Physiol Respir Environ Exerc Physiol. 1980 Apr;48(4):677–683. doi: 10.1152/jappl.1980.48.4.677. [DOI] [PubMed] [Google Scholar]
  27. McManus A. T., Mason A. D., Jr, McManus W. F., Pruitt B. A., Jr Twenty-five year review of Pseudomonas aeruginosa bacteremia in a burn center. Eur J Clin Microbiol. 1985 Apr;4(2):219–223. doi: 10.1007/BF02013601. [DOI] [PubMed] [Google Scholar]
  28. Meyrick B. O., Brigham K. L. The effect of a single infusion of zymosan-activated plasma on the pulmonary microcirculation of sheep. Structure-function relationships. Am J Pathol. 1984 Jan;114(1):32–45. [PMC free article] [PubMed] [Google Scholar]
  29. Obrig T. G., Baltch A. L., Moran T. P., Mudzinski S. P., Smith R. P., Lutz F. Effect of Pseudomonas aeruginosa cytotoxin on thymidine incorporation by murine splenocytes. Infect Immun. 1984 Sep;45(3):756–760. doi: 10.1128/iai.45.3.756-760.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Oppenheimer L., Unruh H. W., Skoog C., Goldberg H. S. Transvascular fluid flux measured from intravascular water concentration changes. J Appl Physiol Respir Environ Exerc Physiol. 1983 Jan;54(1):64–72. doi: 10.1152/jappl.1983.54.1.64. [DOI] [PubMed] [Google Scholar]
  31. Parker J. C., Kvietys P. R., Ryan K. P., Taylor A. E. Comparison of isogravimetric and venous occlusion capillary pressures in isolated dog lungs. J Appl Physiol Respir Environ Exerc Physiol. 1983 Sep;55(3):964–968. doi: 10.1152/jappl.1983.55.3.964. [DOI] [PubMed] [Google Scholar]
  32. Perry M. A. Capillary filtration and permeability coefficients calculated from measurements of interendothelial cell junctions in rabbit lung and skeletal muscle. Microvasc Res. 1980 Mar;19(2):142–157. doi: 10.1016/0026-2862(80)90036-9. [DOI] [PubMed] [Google Scholar]
  33. Pseudomonas aeruginosa infections: persisting problems and current research to find new therapies. Ann Intern Med. 1975 Jun;82(6):819–831. doi: 10.7326/0003-4819-82-6-819. [DOI] [PubMed] [Google Scholar]
  34. Rinaldo J. E., Rogers R. M. Adult respiratory-distress syndrome: changing concepts of lung injury and repair. N Engl J Med. 1982 Apr 15;306(15):900–909. doi: 10.1056/NEJM198204153061504. [DOI] [PubMed] [Google Scholar]
  35. Rippe B., Allison R. C., Parker J. C., Taylor A. E. Effects of histamine, serotonin, and norepinephrine on circulation of dog lungs. J Appl Physiol Respir Environ Exerc Physiol. 1984 Jul;57(1):223–232. doi: 10.1152/jappl.1984.57.1.223. [DOI] [PubMed] [Google Scholar]
  36. Sasaki T., Lutz F. Action of a cytotoxin from Pseudomonas aeruginosa on human leukemic cell lines. Increase in cell permeability to Ca2+ and Mn2+ and lack of stimulation of inositol lipid turnover. FEBS Lett. 1985 Sep 9;189(1):33–36. doi: 10.1016/0014-5793(85)80836-x. [DOI] [PubMed] [Google Scholar]
  37. Scharmann W. Cytotoxic effects of leukocidin from Pseudomonas aeruginosa on polymorphonuclear leukocytes from cattle. Infect Immun. 1976 Mar;13(3):836–843. doi: 10.1128/iai.13.3.836-843.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Scharmann W. Formation and isolation of leucocidin from Pseudomonas aeruginosa. J Gen Microbiol. 1976 Apr;93(2):283–291. doi: 10.1099/00221287-93-2-283. [DOI] [PubMed] [Google Scholar]
  39. Schulz R., Seeger W. Release of leukotrienes into the perfusate of calcium-ionophore stimulated rabbit lungs. Influence of 5-lipoxygenase inhibitors. Biochem Pharmacol. 1986 Jan 15;35(2):183–193. doi: 10.1016/0006-2952(86)90512-5. [DOI] [PubMed] [Google Scholar]
  40. Seeger W., Bauer M., Bhakdi S. Staphylococcal alpha-toxin elicits hypertension in isolated rabbit lungs. Evidence for thromboxane formation and the role of extracellular calcium. J Clin Invest. 1984 Sep;74(3):849–858. doi: 10.1172/JCI111502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Seeger W., Stöhr G., Wolf H. R., Neuhof H. Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer. J Appl Physiol (1985) 1985 Feb;58(2):326–338. doi: 10.1152/jappl.1985.58.2.326. [DOI] [PubMed] [Google Scholar]
  42. Seeger W., Wolf H. R., Neuhof H., Roka L. Release and oxygenation of arachidonic acid: nonspecific triggering and pathophysiological consequences in isolated rabbit lungs. Adv Prostaglandin Thromboxane Leukot Res. 1983;12:99–105. [PubMed] [Google Scholar]
  43. Seeger W., Wolf H., Stähler G., Neuhof H., Róka L. Increased pulmonary vascular resistance and permeability due to arachidonate metabolism in isolated rabbit lungs. Prostaglandins. 1982 Feb;23(2):157–173. doi: 10.1016/0090-6980(82)90043-0. [DOI] [PubMed] [Google Scholar]
  44. Shennib H., Chiu R. C., Mulder D. S., Richards G. K., Prentis J. Pulmonary bacterial clearance and alveolar macrophage function in septic shock lung. Am Rev Respir Dis. 1984 Sep;130(3):444–449. doi: 10.1164/arrd.1984.130.3.444. [DOI] [PubMed] [Google Scholar]
  45. Snashall P. D., Nakahara K., Staub N. C. Estimation of perimicrovascular fluid pressure in isolated perfused dog lung lobes. J Appl Physiol Respir Environ Exerc Physiol. 1979 May;46(5):1003–1010. doi: 10.1152/jappl.1979.46.5.1003. [DOI] [PubMed] [Google Scholar]
  46. Sordelli D. O., Zeligs B. J., Cerquetti M. C., Morris Hooke A., Bellanti J. A. Inflammatory responses to Pseudomonas aeruginosa and Staphylococcus aureus in the murine lung. Eur J Respir Dis. 1985 Jan;66(1):31–39. [PubMed] [Google Scholar]
  47. Stevens R. M., Teres D., Skillman J. J., Feingold D. S. Pneumonia in an intensive care unit. A 30-month experience. Arch Intern Med. 1974 Jul;134(1):106–111. [PubMed] [Google Scholar]
  48. Suttorp N., Seeger W., Uhl J., Lutz F., Roka L. Pseudomonas aeruginosa cytotoxin stimulates prostacyclin production in cultured pulmonary artery endothelial cells: membrane attack and calcium influx. J Cell Physiol. 1985 Apr;123(1):64–72. doi: 10.1002/jcp.1041230111. [DOI] [PubMed] [Google Scholar]
  49. Vito L., Dennis R. C., Weisel R. D., Hechtman H. B. Sepsis presenting as acute respiratory insufficiency. Surg Gynecol Obstet. 1974 Jun;138(6):896–900. [PubMed] [Google Scholar]
  50. Wangensteen O. D., Lysaker E., Savaryn P. Pulmonary capillary filtration and reflection coefficients in the adult rabbit. Microvasc Res. 1977 Jul;14(1):81–97. doi: 10.1016/0026-2862(77)90143-1. [DOI] [PubMed] [Google Scholar]
  51. Webster R. O., Larsen G. L., Mitchell B. C., Goins A. J., Henson P. M. Absence of inflammatory lung injury in rabbits challenged intravascularly with complement-derived chemotactic factors. Am Rev Respir Dis. 1982 Mar;125(3):335–340. doi: 10.1164/arrd.1982.125.3.335. [DOI] [PubMed] [Google Scholar]
  52. Weiner R. N., Reinacher M. Lower nephron toxicity of a highly purified cytotoxin from Pseudomonas aeruginosa in rats. Exp Mol Pathol. 1982 Oct;37(2):249–271. doi: 10.1016/0014-4800(82)90040-5. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES